Los Angeles Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,808
| Closed | -$404K | – | 1087 |
|
|
2024
Q4 | $404K | Buy |
23,808
+375
| +2% | +$6.36K | ﹤0.01% | 861 |
|
|
2024
Q3 | $544K | Buy |
+23,433
| New | +$544K | ﹤0.01% | 842 |
|
|
2023
Q3 | – | Sell |
-10,572
| Closed | -$303K | – | 1115 |
|
|
2023
Q2 | $303K | Sell |
10,572
-1,750
| -14% | -$50.2K | ﹤0.01% | 1000 |
|
|
2023
Q1 | $295K | Hold |
12,322
| – | – | ﹤0.01% | 1011 |
|
|
2022
Q4 | $209K | Hold |
12,322
| – | – | ﹤0.01% | 1135 |
|
|
2022
Q3 | $183K | Hold |
12,322
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q2 | $194K | Sell |
12,322
-47,308
| -79% | -$745K | ﹤0.01% | 1272 |
|
|
2022
Q1 | $1.61M | Buy |
+59,630
| New | +$1.61M | 0.01% | 597 |
|
|
2021
Q3 | – | Sell |
-8,357
| Closed | -$283K | – | 1469 |
|
|
2021
Q2 | $283K | Buy |
+8,357
| New | +$283K | ﹤0.01% | 1410 |
|